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Background: The aim of the study was to characterize RV adaptation to varying loading conditions in patients with
chronic thromboembolic hypertension (CTEPH) before and after pulmonary endarterectomy (PEA). Nearly 4% of patients
with pulmonary embolism develop CTEPH. PEA offers a cure with excellent outcome. By use of cardiovascular magnetic
resonance (CMR) combined with hemodynamic measurements pulmonary arterial elastance (Ea-pulm_i), end-systolic right
ventricular elastance (Ees-RV_i) and ventriculo-arterial coupling (Ea-pulm_i/Ees-RV_i) can be studied before and after PEA.
Methods: Sixty-five patients (mean age 41 ± 12 years, 28 female) underwent CMR pre- and post-PEA. Ejection
fraction (EF), end-diastolic (EDVi), end-systolic (ESVi), and stroke (SVi) volumes were indexed for body surface area.
Ea-pulm_i was calculated as pulmonary artery mean pressure (mPAP)/SVi, and Ees-RV_i as mPAP/ESVi.
Results: mPAP decreased from 47 ± 12 to 25 ± 9 mmHg, p =0.0001. Ea-pulm_i was increased before PEA and normalized
afterwards (2.8 ± 2.1 vs. 0.85 ± 0.4 mmHg/ml/m2, p =0.0001). Ees-RV_i was depressed before and after PEA (0.72 ± 0.27
vs. 0.66 ± 0.3 mmHg/ml/m2, p =0.13). EF improved from 25 ± 12% to 46 ± 10%, p =0.0001, because ventriculo-arterial
coupling was restored (4.2 ± 3 vs. 1.4 ± 0.6, p =0.0001). EDVi and ESVi mproved significantly (EDVi 92 ± 32 to 72 ± 23 ml,
p =0.0001; ESVi 69 ± 31 to 41 ± 18 ml, p =0.0001).
Conclusion: RV function is largely determined by afterload and returns to normal once afterload is normalized. This is
paralleled by a significant improvement of CMR indices of right ventricular remodelling.
Keywords: Cardiovascular magnetic resonance, Chronic thromboembolic pulmonary hypertension, Pulmonary
endarterectomyBackground
Chronic thromboembolic pulmonary hypertension (CTEPH)
is an important and frequent cause of pulmonary hyper-
tension. The WHO has therefore acknowledged it as an
independent entity in the renewed Dana Point Classifica-
tion [1]. Estimates of its incidence after acute pulmonary* Correspondence: andreas.rolf@me.com
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unless otherwise stated.embolism vary between 0.5 and 3.8% [2-4]. Detailed epide-
miologic data are available from the UK, where dedicated
pulmonary hypertension centers are monitored by the
National Audit of Pulmonary Hypertenion (NAPH). Per
year and per one million population 124 patients were
seen, of which 19.2 percent were classified as having
CTEPH, in the past annual surveillance period 143
patients underwent pulmonary endarterectomy (PEA)
[5]. CTEPH is the only form of pulmonary hypertension
that offers a potential cure PEA with excellent long-term
results [6,7].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CTEPH are a consequence of incomplete thrombus
resolution, remodelling of the thrombus, and neoangio-
genesis [8]. In later stages of the disease vascular
remodelling extends beyond the central vessels and also
involves the vascular bed not primarily affected by
thrombemboli. At this stage the histopathology of the
vasculature resembles that found in idiopathic pulmonary
arterial hypertension [9]. Consequently, mean pulmon-
ary arterial pressure (mPAP) and resistance (PVR) rise
and are typically on the order of 49 ± 19 mmHg and
1,015 ± 454 dyn*sec*cm-5, respectively, in a surgically
treated cohort [6]. This in turn leads to hemodynamic
changes and remodelling of the right ventricle (RV).
End-systolic and end-diastolic volumes increase while
the ejection fraction deteriorates. Furthermore, diastolic
properties of both ventricles are affected as diastolic
pressures of the RV increase and a leftward shift of the
septal wall ensues [10].
Deterioration of RV function can be readily assessed
by cardiovascular magnetic resonance (CMR), which has
emerged as the gold standard for evaluating RV function
as it allows full coverage of the complex geometry of the
RV [11-14]. This decline in RV function is preceded by a
rise in RV afterload. In the early stages of the disease
contractile properties of the RV compensate for this
increase in afterload. Once the compensation is insuffi-
cient, RV function will quickly decrease.
For a more in-depth understanding of this process it
is important to consider arterial load and ventricular
performance independently as well as their coupling.
Ea-pulm,, the effective pulmonary artery elastance, is a
well-validated measure of arterial load; Ees-RV characterizes
the effective right ventricular elastance and is a measure
of contractiliy. Their ratio Ees-RV/Ea-pulm describes
ventriculo-arterial coupling, which should have a value
close to 1.0 in order to achieve sufficient energy transfer
from the RV to the pulmonary vasculature [15-19].
Traditionally, these parameters have been derived from
conductance catheter measurements or simultaneously
acquired CMR volumetric and right heart catheter (RHC)
data [17]. Both methods are time-consuming, require
specialized catheters, and are hence not suitable for
clinical routine. Therefore, approximation methods have
been proposed that are either completely non-invasive or
combine CMR measurements and routine RHC measure-
ments registered outside the MR suite [15,20-22].
In this study of 65 patients who underwent PEA for
CTEPH, we combined cine-cardiac CMR data and hemo-
dynamic data available from routine right heart cathe-
terization to study RV adaption to pressure overload and
reverse remodelling of the RV before and after surgery.
Although we are not aware of any study directly com-
paring CMR to Echo with respect to their accuracy ofreflecting right ventricular remodelling in terms of volumes
and mass, we are convinced that CMR is superior to Echo
in this setting. While there are well validated echocardio-
graphic indices of right ventricular function (TEI index,
TAPSE etc.) volumetric evaluation of the RV is difficult
with echo. Geometric assumptions on which left ventricu-
lar volumetric quantification is based, are not valid for the
triangular shaped RV. In that respect CMR evaluation of
the RV yields additional information not available from
echo. D'Armini et al. report longitudinal data from CTEPH
patients, which show reduced RV volumes after PEA,
which are sustained after 12 month. The hemodynamic
improvement, they found was paralleled by improved RV
volumes and function. However the authors did not link
hemodynamic data and CMR measurements.
CTEPH is an excellent setting to study these changes as
it behaves like an on/off phenomenon of PH before and
after surgery and is therefore the only entity of pulmonary
hypertension, that allows to study potential reversal of
CMR and hemodynamic indices of RV remodelling.
In this paper we try to establish a link between remodel-
ling and the possible physiological bases for the volumetric




We retrospectivley defined a two year period during which
we screened all 159 patients who were referred to and
underwent PEA.
Of these Sixty-five consecutive patients completed CMR
as part of their perioperative routine workup and were
enrolled in this study.
Indication for CMR was at the discretion of both the
attending thoracic surgeon and cardiologist and was based
on the need for further evaluation of right ventricular
function.
Contraindications for CMR and exclusion criteria were
renal failure with a glomerular filtration rate below
30 ml/min/1.73 m2, incompatible metallic implants,
known intolerance to gadolinium, and claustrophobia or
the unability to lie supine for the duration of the proto-
col because of dyspnea.
The primary diagnosis of CTEPH was based on right
heart catheter measurements, perfusion/ventilation scintig-
raphy and pulmonary angiography findings. All patients
gave written informed consent. The study was approved by
the ethics committee of the University of Gießen, Germany.
Hemodynamic background and formulas
Elastance describes the change in pressure for a given
change in volume. Hence, effective arterial elastance of
the pulmonary artery can be approximated by the follow-
ing formula [19,20,22]:
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where RVESP is the end-systolic pressure of the RV and
SV is the stroke volume of the RV. RVESP can be further
approximated by [19]
RVESP ≈ mPAP ð2Þ
where mPAP is the systolic pressure of the pulmonary
artery measured by routine RHC. Thus, effective arterial
elastance can be simplified as
Ea−pulm≈ mPAP=SV ð3Þ
Ea-pulm is a reliable measure of the load faced by the
right ventricle during systole and accounts for pulmonary
vascular resistance, compliance, and impedance, and thus
also includes the pulsatile components of arterial load
[19,20].
Similarly, Ees-RV characterizes the chamber elastance at
end-systole and can be approximated by [19,20]
Ees−RV≈mPAP=RVESV ð4Þ
where RVESV is the right ventricular end-systolic
volume.
In order to provide sufficient energy transfer from the
ventricle to the arterial system these properties should be
equivalent. The ratio of these parameters, the ventriculo-
arterial coupling, is defined as Ea-pulm/Ees-RV. Uncoupling
describes the situation in which Ees-RV cannot compensate
the disproportionate rise of Ea-pulm, and rapid deterior-
ation of RV function ensues [19]. Ea-pulm_i and Ees-RV_i as
well as Ea-pulm/Ees-RV_i were indexed for body surface area
(BSA).
Cardiac MRI (CMR)
Volumetric measurements of right ventricular function
were performed in a standard fashion by cine CMR
covering the RV in short-axis slices from base to apex.
Typical sequence parameters were TE 1.5 ms, TR
38.8 ms, 13 segments, 1.6 × 2.2 mm in-plane resolution,
flip angle 70°, bandwidth 930 Hz/px, slice thickness 8 mm,
interslice gap 2 mm.
Endocardial and epicardial contours were drawn on
the RV to determine end-diastolic (EDV), end-systolic
(ESV) and stroke (SV) volumes as well as RV myocardial
mass (RVMASS) and ejection fraction (EF) using CAAS
Software (Pie Medical, Maastricht, the Netherlands).
Trabeculations were excluded from the myocardium. All
volumetric parameters were normalized for BSA (EDVi,
ESVi, RVMASSi, SVi). Median time between preoperative
CMR and surgery was 1 day (IQR 1- 3). Median time
between postoperative CMR and surgery was 12 days
(IQR 11-12).Right Heart Catheter Measurements (RHC)
RHC measurements were performed using standard Swan
Ganz catheters introduced via 6 F sheaths through the in-
ternal jugular, subclavian, or femoral vein. Measurements
were obtained from routine RHC procedures during the
preoperative evaluation and postoperative monitoring on
the intensive care unit, median time difference between
RHC and CMR preoperatively was 43 days (IQR 36 - 56)
and median time between postoperative RHC and postop-
erative CMR was 11 days (IQR 10 - 11). Patients were not
under therapy with vasoactive agents during postoperative
RHC measurements.
Statistics
The Shapiro-Wilk test was used to test the data for nor-
mality. Metric values are presented as means ± SD, and
counts are presented as absolute frequencies and per-
centages. Student’s t-test for paired data was used to test
for significant differences between pre- and postopera-
tive values. A chi-square test was used to compare count
variables. An alpha error less than 0.05 was accepted as
significant. All tests were computed using STATA11
(StataCorp, College Station, Texas, USA).
Results
Of the sixty-five consecutive patients enrolled in the study,
28 were female, the mean age was 56.7 ± 16 years, and the
mean BSA was 1.96 m2, the majority of patients was
NYHA class III, 6 minute walking distance was 386 ± 116
before surgery and 399 ± 120 after surgery (Table 1).
mPAP was markedly increased before PEA and signifi-
cantly dropped after surgery (47 ± 12 vs. 25 ± 9 mmHg,
p =0.0001). RV afterload, as represented by the effective
arterial elastance Ea-pulm_i, was pathologically increased
before PEA and decreased to near normal values after
PEA (2.8 ± 2.1 vs. 0.85 ± 0.4 mmHg/ml/m2, p =0.0001).
There was a lower, but not significantly lower right
ventricular elastance Ees-RV_i after surgery, with only mar-
ginally changed absolute values (0.72 ± 0.27 vs. 0.66 ±
0.3 mmHg/ml/m2, p =0.13). Consequently, there was
marked ventriculo-arterial uncoupling Ea-pulm/Ees-RV_i
before PEA, which significantly improved to near normal
values after surgery (4.2 ± 3 vs. 1.4 ± 0.6, p =0.0001) com-
pare Figure 1.
The ejection fraction EF was severely depressed before
PEA and significantly improved afterwards (25 ± 12 vs.
46 ± 10%, p =0.0001). Right ventricular volumes (EDVi
and ESVi) significantly decreased after PEA (92 ± 32 vs.
72 ± 23 ml/m2, p =0.0001; 69 ± 31 vs. 41 ± 18 ml/m2,
p =0.0001, respectively). Conversely, SVi improved signifi-
cantly after PEA (22 ± 10 vs. 32 ± 9 ml/m2, p =0.0001).
RVMASSi was increased before PEA and decreased sig-
nificantly afterwards but was not clinically relevant (32 ± 9
vs. 30 ± 9 mg/m2, p =0.03). Ea_pulm_i was well correlated
Table 1 patient characteristics, remodelling and
hemodynamic parameters
Before PEA After PEA p value
Mean age (years) 56.7 ± 16
Female gender (%) 28(43)
BSA (m2) 1.96 ± 0.22
NYHA class II(%) 7(11)
NYHA class III(%) 48(74)
NYHA class IV(%) 10(15)
6 minute walking distance 386 ± 116 399 ± 120 0.48
mPAP (mmHg) 47 ± 12 25 ± 9 0.0001
PVR (dyn*sec/cm5) 531 ± 176 331 ± 278 0.01
PCWP mmHg 8.7 ± 3.7 10.7 ± 5.7 0.19
CO (l/min) 4.7 ± 1.5 4.6 ± 1.3 0.7
EDVi (ml/m2) 92 ± 32 72 ± 23 0.0001
ESVi (ml/m2) 69 ± 31 41 ± 18 0.0001
SVi (ml/m2) 22 ± 10 32 ± 9 0.0001
RVMASSi (ml/m2) 32 ± 9 30 ± 9 0.03
EF (%) 25 ± 12 46 ± 10 0.0001
Ea-pulm_i (mmHg/ml/m
2) 2.8 ± 2.1 0.85 ± 0.4 0.0001
Ees-RVi (mmHg/ml/m
2) 0.72 ± 0.27 0.66 ± 0.3 0.13
Ea-pulm/Ees-RV 4.2 ± 3 1.4 ± 0.6 0.0001
Hemodynamic and volumetric results before and after PEA.
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postoperatively Ea_pulm_i vs. mPAP (r =0.584, p =0.0004)
compare Figure 2.
Compare Table 1 for an overview of the results.
Discussion
In contrast to pulmonary hypertension of other etiologies,
CTEPH is potentially curable. After successful PEA,
pulmonary vascular hemodynamics can return to normalChange of effective pulmonary arterial 
elastance before and after PEA
Change of endsystol
elastance before 
Figure 1 Change of pulmonary arterial load, RV contractile state and ve
ventriculo-arterial coupling is restored despite a continuously depressed cont[6]. Previous studies have shown that the RV has the
extraordinary ability to undergo reverse remodelling after
PEA, despite severely depressed function before surgery
[23,24]. To the best of our knowledge this is the first study
that examines RV adaptation to increased RV afterload in
patients with CTEPH.
In combination with routine hemodynamic data, CMR
offers the possibility to independently study RV function,
remodelling, afterload, and contractile properties. Using
this approach, we sought to determine how the RV
adapts to increased afterload and what role RV afterload
plays in the reverse remodelling of the RV.
Several methods have been proposed to quantify after-
load without the use of conductance catheters for the
right as well as the left ventricle, some even completely
non-invasively [15,16,20,22,25]. The simplified method of
calculating Ea-pulm_i and Ees-RV_i from mPAP and volumet-
ric measurements seemed most reasonable to us, as it was
simple to calculate and hemodynamic data were readily
available over a long period postoperatively. Also, it was
found to correlate well with PVR and complex methods to
quantify Ea by several authors [15,20,22]. The negligence
of the pulmonary capillary wedge pressure tends to over-
estimate Ea-pulm, but as we performed a longitudinal study,
examining the same patients before and after PEA, this
seemed irrelevant.
We found markedly increased pulmonary arterial load
Ea-pulm_i before PEA that normalized after surgery. Data on
normal values for Ea-pulm_i and RV volumetric parameters
are sparse. On the basis of a normal value for mPAP of 10
to 20 mmHg and a stroke volume index of 55 ± 9 ml[14], a
normal Ea-pulm_i can be estimated as ≈ 0.3 mmHg/ml/m
2.
Consequently, the values of arterial load that we found were
almost 9-fold higher than this calculated normal limit.
These values are higher than published by Sanz et al. [20],
who found an Ea-pulm_i of 0.88 in a cohort of 124 PHic right ventricular 
and after PEA
Change of ventriculo arterial coupling 
before and after PEA
ntriculo-arterial coupling. Because arterial load decreases post-PEA,
ractile state.
Change of Ejection Fraction
pre and post PEA
Change of Endsystolic Volume Index
pre and post PEA
Change of Enddiastolic Volume Index
pre and post PEA
Change of Stroke Volume Index
pre and post PEA
Figure 2 Change of ejection fraction and volumes. The RV shows reverse remodelling as early as 10 days post-PEA.
Rolf et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:96 Page 5 of 7
http://jcmr-online.com/content/16/1/96patients of varying etiology and a similar mPAP (42 mmHg);
however, only 3 patients of this cohort had CTEPH and
ejection fraction as well as stroke volumes were much
lower in our cohort, hence Ea-pulm_i higher (RVEF 37% as
compared to our 25% and 35.5 ml/m2 as compared to our
22 ml/m2 ). Kühne et al. reported a similar Ea-pulm of 2.7 in
a series of 6 patients with an mPAP of 56 mmHg, which
was derived from simultaneously measured pressure-
volume curves [17]. This value is slightly higher than that
of our cohort; however, mPAP was also higher than that of
our cohort by 13 mmHg. Conversely, Amin et al. found an
Ea-pulm (not normalized for BSA) of 0.75, which is lower
than our values by the same degree, as mPAP in their study
group was lower and stroke volumes were higher [22].
Thus, within the context of other published studies, our
measurements seem plausible and demonstrate markedly
increased RV afterload before PEA. Consequently, we also
observed the typical remodelling of the RV with increased
RVMASSi and greater volumes.
The contractile state of the RV was depressed before
and after PEA, with a trend towards lower values after
surgery and only marginally changed absolute values. It
is a typical response of the heart to increase Ees in theface of rising afterload, which has been intensively studied
in the systemic circulation. This is frequently observed in
hypertensive heart disease, where Ees compensates for
increasing loading conditions until Ea increases dispropor-
tionately and Ees cannot rise accordingly [26-29]. In a
swine model of repetitive acute pulmonary embolism,
Kerbaul et al. found increasing Ees-RV in the initial period
after the first embolism, which later decreased with rising
afterload and reached levels below the initial value [30].
Ees-RV_i values reported here are in good agreement with
other studies [20,31]. Surprisingly Ees-RV_i did not improve
immediately after surgery. However, it is important to note
that ESVi decreased dramatically after PEA and that the
computation of Ees-RV_i is based on a much smaller
ESVi. It is therefore essential to study Ees-RV_i in relation
to Ea-pulm_i.
The effective ventriculo-arterial coupling between pul-
monary arterial vasculature and RV expressed as the
ratio Ea-pulm_i/Ees-RV_i was markedly increased before PEA,
indicating severe uncoupling. However, RV afterload
dropped by 70% after PEA, and thus ventriculo-arterial
coupling was restored despite the fact that contractile
properties were still compromised, reflecting sufficient
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tem. The most efficient energy transfer was found to be at
an Ea/Ees ratio of 0.6 to 1.2 for the left ventricle [27,32-34];
for the RV data on normal values are sparse. Kühne et al.
reported an Ea/Ees ratio of 0.52 for controls and 0.91 for
PH patients (in the original work Ees/Ea was reported; this
is the inverse) [17], Sanz et al. reported an Ea/Ees ratio of
0.37 for controls and 1.26 for PH patients [20]. Hence, in
light of data from these other publications, preoperative
values of 4.2 indicate marked uncoupling of right ventricle
and pulmonary artery. The postoperative value of 1.4 can
probably be considered to be a significant improvement
towards normal ventriculo-arterial coupling.
Essentially, PEA reverses the increased RV afterload
like an on/off phenomenon in these CETPH patients.
Our data show that the RV function is largely afterload
dependent and that it can return to normal once normal
pulmonary arterial afterload decreases and ventriculo-
arterial coupling of the RV is restored. This is in good
agreement with data of Kerbaul et al., who showed in
an animal model of pulmonary arterial embolism that
levosimendan is superior to dobutamine in improving
ventriculo-arterial coupling because it not only increases
Ees (as dobutamine does) but sufficiently lowers Ea.
Although contractility was more enhanced under dobuta-
mine treatment, ventriculo-arterial coupling was better
under levosimendan because afterload was nearly half the
value found under dobutamine [30,35].
The Ea-pulm_i/Ees-RV_i ratio and the ejection fraction
showed a curvilinear relationship, with a steep decline of
the ejection fraction in the early phase of uncoupling
(compare Figure 3).
Hemodynamic changes were paralleled by reverse
remodelling of RV volumes and an improvement in theCurvilinear Relationship 
Ea-pum_i/Ees-RV_i vs. EF
Figure 3 Curvilinear relationship between ventriculo-arterial
coupling and EF. Once uncoupling between RV and pulmonary
vasculature has occurred, the EF declines steeply.ejection fraction. ESVi decreased by 40% while RV-EF
almost doubled. This has been described previously
[24,36]; however, it is remarkable that the RV maintains
the ability to undergo reverse remodelling despite its
severely reduced function before PEA. Of note, the RV
was also considerably hypertrophied, suggesting myocyte
hypertrophy as well as interstitial adaptation are involved.
Nevertheless, RV volumes and EF values returned to
almost normal. As RV afterload and ventriculo-arterial
coupling changed most substantially, these parameters
seem to have the pivotal role in remodelling and reverse
remodelling. The instant remodelling of the RV also
suggests that we did not simply measure a short-term
hemodynamic effect but a lasting restoration of ventricu-
lar and pulmonary arterial function.
Limitations
The inferences made in this study are based on surrogate
markers and not on the gold standard of conductance
catheters. However, these markers have been thoroughly
validated in previous studies [20,22,30]. This is the largest
cohort of CTEPH patients published to date and all
parameters have been evaluated in a longitudinal setting,
allowing conclusions from our data about the general
physiology of the right ventricle.
In this paper we have looked at remodelling in terms
of changed RV-volumes, mass and ejection fraction and
a possible physiological basis for these changes. These
findings do not allow to make inferences to histological
remodelling. With the advent and further improvement
of T1 Mapping techniques, we might be able to correlate
our findings with interstitial remodelling in the future.
Conclusion
By combining readily available data from routine RHC
measurements and CMR volumetric data in CTEPH pa-
tients, we were able to quantify RV contractile properties
and pulmonary arterial afterload. We demonstrated that
RV function is largely determined by afterload and returns
to normal once ventriculo-arterial coupling and effective
pulmonary arterial elastance are restored by PEA.
This makes CMR in combination with simple RHC
measurements an ideal tool to study RV properties in the
follow up of PH patients in the clinical and study setting.
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